Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Wagenmann

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Laryngo- Rhino- Otologie|June 24, 2020
L Klimek, U Förster-Ruhrmann, S Becker, et al.
Laryngo- Rhino- Otologie|August 29, 2020
L Klimek, A G Beule, U Förster-Ruhrmann, et al.
Laryngo- Rhino- Otologie|September 14, 2021
U Förster-Ruhrmann, A G Beule, S Becker, et al.
Rhinology|January 13, 2024
EPOS2020/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNPW J Fokkens, E De Corso, V Backer, et al.
Allergy|January 30, 2018
EAACI Position paper on the standardization of nasal allergen challengesJ Augé, J Vent, I Agache, et al.
Rhinology|September 29, 2020
EUFOREA treatment algorithm for allergic rhinitisP W Hellings, G Scadding, C Bachert, et al.
Laryngo- Rhino- Otologie|April 2, 2026
[Use of Omalizumab-biosimilars for CRSwNP in the German Health Care System - a Position Paper of the German Societies for Allergy AeDA and ORL DGHNO-KHC]L Klimek, F Bärhold, U Förster-Ruhrmann, et al.
Rhinology|September 10, 2025
Indication for biologics in a real-world cohort of dupilumab treated chronic rhinosinusitis with nasal polyps patients according to international recommendations: evidence from the European CRS Outcome Registry (CHRINOSOR)G Mortuaire, S F Seys, J de Kinderen, et al.
Rhinology|February 17, 2026
Real-world effectiveness of omalizumab in patients with chronic rhinosinusitis with nasal polyps (CRSwNP): findings from CHRINOSORT Bartosik, S F Seys, J de Kinderen, et al.
Rhinology|December 12, 2022
The EUFOREA pocket guide for chronic rhinosinusitisP W Hellings, W J Fokkens, R Orlandi, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Laryngo- Rhino- Otologie|June 24, 2020
L Klimek, U Förster-Ruhrmann, S Becker, et al.
Laryngo- Rhino- Otologie|August 29, 2020
L Klimek, A G Beule, U Förster-Ruhrmann, et al.
Laryngo- Rhino- Otologie|September 14, 2021
U Förster-Ruhrmann, A G Beule, S Becker, et al.
Rhinology|January 13, 2024
EPOS2020/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNPW J Fokkens, E De Corso, V Backer, et al.
Allergy|January 30, 2018
EAACI Position paper on the standardization of nasal allergen challengesJ Augé, J Vent, I Agache, et al.
Rhinology|September 29, 2020
EUFOREA treatment algorithm for allergic rhinitisP W Hellings, G Scadding, C Bachert, et al.
Laryngo- Rhino- Otologie|April 2, 2026
[Use of Omalizumab-biosimilars for CRSwNP in the German Health Care System - a Position Paper of the German Societies for Allergy AeDA and ORL DGHNO-KHC]L Klimek, F Bärhold, U Förster-Ruhrmann, et al.
Rhinology|September 10, 2025
Indication for biologics in a real-world cohort of dupilumab treated chronic rhinosinusitis with nasal polyps patients according to international recommendations: evidence from the European CRS Outcome Registry (CHRINOSOR)G Mortuaire, S F Seys, J de Kinderen, et al.
Rhinology|February 17, 2026
Real-world effectiveness of omalizumab in patients with chronic rhinosinusitis with nasal polyps (CRSwNP): findings from CHRINOSORT Bartosik, S F Seys, J de Kinderen, et al.
Rhinology|December 12, 2022
The EUFOREA pocket guide for chronic rhinosinusitisP W Hellings, W J Fokkens, R Orlandi, et al.
Pageof 7